• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Havn Life Sciences Inc (OP: HAVLF )

    0.0001 UNCHANGED
    Last Price Updated: 1:06 PM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.0001
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0001
    Today's Range 0.0001 - 0.0001
    52wk Range 0.0001 - 0.1500
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
    Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy. 
    Via Benzinga
    HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
    Biotech psychedelics company HAVN Life Sciences Inc. (OTC: HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July... 
    Via Benzinga

    Performance

    YTD
    -99.83%
    -99.83%
    1 Month
    N/A
    N/A
    3 Month
    N/A
    N/A
    6 Month
    -99.11%
    -99.11%
    1 Year
    -99.17%
    -99.17%

    More News

    Read More
    Learn About HAVN Life's New Shares Consolidation, What Changes And What Remains
    Via Benzinga
    HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
    Via Benzinga
    HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
    From HAVN Life Sciences Inc.
    Via AccessWire
    HAVN Life Sciences (CSE: HAVN) (OTC: HAVLF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
    Via Investor Brand Network
    Topics Economy
    Exposures Supply Chain
    HAVN Life Sciences (HAVLF) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
    Via Investor Brand Network
    Topics Economy
    Exposures Supply Chain
    Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind'
    Via Benzinga
    HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
    Via Benzinga
    Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
    Via Benzinga
    HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
    Via Benzinga
    Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
    Via Benzinga
    Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
    From Stock News Now
    Via AccessWire
    There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
    Via Benzinga
    Former Tilray CEO Joins Psychedelics Company
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) Featured in Virtual Coverage of LD Micro’s Main Event
    Via Investor Brand Network
    Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
    Via Benzinga
    HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
    From Havn Life Sciences Inc.
    Via AccessWire
    Exposures Product Safety
    HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
    From Havn Life Sciences Inc.
    Via AccessWire
    Topics Supply Chain
    Exposures Supply Chain
    Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
    Via Benzinga
    Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
    Via Benzinga
    HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
    From Havn Life Sciences Inc.
    Via AccessWire
    HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
    From Havn Life Sciences Inc.
    Via AccessWire
    Topics Cannabis
    Exposures Cannabis
    Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
    Via Benzinga
    HAVN Life Natural Health Products Now Available on Amazon.ca
    From Havn Life Sciences Inc.
    Via AccessWire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.